Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
Join our Virtual Triathlon Challenge and swim, cycle and run while raising money to fund Breakthrough T1D’s life-changing type 1 research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > About Breakthrough T1D UK & our impact > Our research > Research projects > Improving mental health and blood glucose management in people with type 1 diabetes and depression
Dr Leslie Johnson
We understand the impact type 1 diabetes can have on the mental health of everyone connected to the condition. People with type 1 often experience depression or anxiety, which can lead to worsening mental and physical health. So, we have partnered with MQ Mental Health Research to co-fund Dr Leslie Johnson’s research project to provide better care for adults with type 1 and depression. She will do this by adapting and testing an evidence -based care model that aims to improve screening and testing for depression within routine diabetes care.
The model Leslie will test involves interventions including support with self-management from a care coordinator who is not a doctor, decision support tools and specialist case reviews. The self-management support engages and empowers patients to take an active role in making decisions about their diabetes healthcare. While the tailored follow-up support supports people to maintain their self-management to help prevent depression and anxiety relapse. Overall, Leslie hopes the care model will improve quality of life.
People with type 2 diabetes have found that this care model substantially benefits their mental and physical health by reducing blood sugar levels and symptoms of depression and anxiety. Leslie will adapt the model to help adults living with type 1 and mental health conditions reduce their symptoms of depression and improve their blood glucose management.
Leslie’s research team will gather feedback from people with type 1 and healthcare professionals about integrating mental health and diabetes care through focus group sessions and interviews. They will then form a community advisory board involving people with diabetes and healthcare leaders who will help them adapt the components of the care model for people with type 1. They will make sure the adapted model addresses any barriers that were identified from the feedback collected.
Leslie will recruit 80 adults with type 1 who have clinically significant symptoms of depression to take part in her study. Over 12 months, half the group will receive their usual care while the others receive the extra support in the care model. After a further six months of observation, the researchers will compare the differences between the two groups in depressive symptoms, anxiety scores, and HbA1c levels, measured at the start and after 12 and 18 months.
The results from this study will provide information on incorporating mental health care into routine diabetes clinics. Leslie hopes to be able to scale her project up to extend the depression and diabetes care model to more people with type 1. This will improve the quality of diabetes care by helping healthcare professionals detect depression and anxiety in people with type 1 and provide access to mental health treatment. Once integrated into healthcare systems, this care model will also help empower individuals with type 1 and mental health issues to improve their mental and physical health and overall quality of life.
The latest Breakthrough T1D UK Improving Lives Research Strategy sets out a roadmap for the future of psychosocial healthcare research for people with type 1. Our mission is to inform science, train healthcare professionals, increase access to psychosocial services, and improve the knowledge of people with type 1 through our programme of behavioural health and psychology research. We are funding Dr Emma Berry to develop a digital psychosocial wellbeing tool for people with type 1.
Dr Matthew Anson is studying whether hybrid closed loop technology, also known as an artificial pancreas, affects the worsening of diabetic eye disease.
Dr Samet Sahin is developing a simple tool to allow healthcare professionals to quickly and easily check someone’s C-peptide levels, a measure of how much insulin they are releasing.
Dr Thomas George Hill is studying a type of pancreatic islet cell, called a delta cell, which he thinks could be targeted with a treatment to help prevent low blood glucose in type 1 diabetes.
Dr Richard Pulsford is developing a visual tool for people with type 1 diabetes that predicts the likelihood of their blood glucose going too low during exercise
